Related references
Note: Only part of the references are listed.Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling
Emmanuel Grolleau et al.
Biomolecules (2023)
Mass spectrometry-based characterization of histones in clinical samples: applications, progresses, and challenges
Roberta Noberini et al.
FEBS JOURNAL (2022)
Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
Sohan Punia et al.
BMC GASTROENTEROLOGY (2021)
A novel proteomics approach to epigenetic profiling of circulating nucleosomes
Priscilla Van den Ackerveken et al.
SCIENTIFIC REPORTS (2021)
Current Methods of Post-Translational Modification Analysis and Their Applications in Blood Cancers
Katie Dunphy et al.
CANCERS (2021)
Characterizing circulating nucleosomes in the plasma of dogs with lymphoma
Christopher Dolan et al.
BMC VETERINARY RESEARCH (2021)
Discovery of a Non-Nucleoside SETD2 Methyltransferase Inhibitor against Acute Myeloid Leukemia
David Bajusz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study
Stephen J. Bagley et al.
CLINICAL CANCER RESEARCH (2020)
Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas
Joon Young Hur et al.
ANNALS OF HEMATOLOGY (2020)
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
Xiaoguang Wang et al.
PROTEIN & CELL (2020)
An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia
Alok Swaroop et al.
ONCOGENE (2019)
Profiling of Epigenetic Features in Clinical Samples Reveals Novel Widespread Changes in Cancer
Roberta Noberini et al.
CANCERS (2019)
H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy
Marta Halasa et al.
CELLS (2019)
Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma
Mahsa Eskandari et al.
BLOOD RESEARCH (2019)
Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
Alexander I. Salter et al.
SCIENCE SIGNALING (2018)
Emerging EZH2 Inhibitors and Their Application in Lymphoma
Jennifer K. Lue et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2018)
PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival
Xiaoqing Lu et al.
BLOOD (2018)
Deciphering lymphoma pathogenesis via state-of-the-art mass spectrometry-based quantitative proteomics
Konstantina Psatha et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer
Louise Rasmussen et al.
Oncotarget (2017)
Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
Jean-Francois Rahier et al.
CLINICAL EPIGENETICS (2017)
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
Peter McAnena et al.
CANCERS (2017)
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Anupama Reddy et al.
CELL (2017)
Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases
Guillermo Rodriguez-Hernandez et al.
CANCER RESEARCH (2017)
Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice
Idoia Garcia-Ramirez et al.
BLOOD (2017)
Histone H3 Dynamics Reveal Domains with Distinct Proliferation Potential in the Arabidopsis Root
Sofia Otero et al.
PLANT CELL (2016)
Mapping H4K20me3 onto the chromatin landscape of senescent cells indicates a function in control of cell senescence and tumor suppression through preservation of genetic and epigenetic stability
David M. Nelson et al.
GENOME BIOLOGY (2016)
Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer
Ugur Gezer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
Monika Bauden et al.
CLINICAL EPIGENETICS (2015)
Global Phosphoproteomic Profiling Reveals Distinct Signatures in B-Cell Non-Hodgkin Lymphomas
Delphine Rolland et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Expression of Histone Deacetylases in Diffuse Large B-cell Lymphoma and Its Clinical Significance
Sung Hak Lee et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2014)
Histone core modifications regulating nucleosome structure and dynamics
Peter Tessarz et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity
Yuhki Yokoyama et al.
BREAST CANCER RESEARCH (2014)
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma
Melanie R. Hassler et al.
EPIGENOMICS (2013)
Asymmetrically Modified Nucleosomes
Philipp Voigt et al.
CELL (2012)
Levels of histone acetylation in thyroid tumors
Cinzia Puppin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Laura Pasqualucci et al.
NATURE (2011)
The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma
J. A. Anderton et al.
ONCOGENE (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
Targeting histone deacetyalses in the treatment of B- and T-cell malignancies
Jasmine Zain et al.
INVESTIGATIONAL NEW DRUGS (2010)
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas
S. Hohaus et al.
ANNALS OF ONCOLOGY (2009)
Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas
Lena Marquard et al.
HISTOPATHOLOGY (2009)
Clinical relevance of circulating nucleosomes in cancer
Stefan Holdenrieder et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
B. Sadikovic et al.
CURRENT GENOMICS (2008)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments
Susanne Mueller et al.
BMC CANCER (2006)
Value of [F-18]fluorodeoxyglucose-positron emission tomography in managing patients with aggressive non-Hodgkin's lymphoma
Michel Meignan et al.
CLINICAL LYMPHOMA & MYELOMA (2006)
Analysis of BCL6-interacting proteins by tandem mass spectrometry
RR Miles et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Differential DNA methylation of gene promoters in small B-cell lymphomas
JY Guo et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer
S Holdenrieder et al.
CLINICAL CANCER RESEARCH (2004)
Two-dimensional molecular profiling of mantle cell 2 lymphoma
F Antonucci et al.
ELECTROPHORESIS (2003)
Circulating nucleosomes and response to chemotherapy:: An in vitro, in vivo and clinical study on cervical cancer patients
C Trejo-Becerril et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Cell kinetics and cell cycle regulation in lymphomas
L Leoncini et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Share Paper
